UK company announcements filtered and explained for private investors.
McBride plc (MCB) · 2026-06-12
McBride said FY26 and FY27 adjusted EBITA will be 5-10% lower than current analysts' expectations, based on consensus of £64.2m for FY26 and £70.6m for FY27. Sustained input cost increases linked to the Middle East conflict have outpaced price recovery actions, with the financial impact concentrated in Q4 FY26 and Q1 FY27.
Alternative Income REIT PLC (AIRE) · 2026-06-12
Alternative Income REIT received a firm 70p per share all-cash offer from Glenstone REIT, valuing the company at £56.35m. The offer represents a 1.45% premium to the latest closing price and requires a 50% acceptance threshold.
Virgin Wines UK plc (VINO) · 2026-06-12
Virgin Wines UK plc cut its FY26 guidance, citing macro pressures and higher costs. The company now expects revenue of c.£61m and an EBITDA loss of £200k, both below market expectations. It remains debt-free despite signing a lease for a new warehouse facility.
Verici Dx plc (VRCI) · 2026-06-12
Verici Dx plc raised £2.6m in gross proceeds through a placing of 700,000,000 shares and a WRAP Retail Offer of 53,345,832 shares. The issue of the WRAP Retail Offer Shares is conditional upon the passing of certain resolutions at a General Meeting expected to be held on 22 June 2026 and admission to trading on AIM.
EKF Diagnostics Holdings plc (EKF) · 2026-06-12
EKF Diagnostics Holdings plc purchased 50,000 ordinary shares at 24.8p on 11 June 2026. These shares will be cancelled. Total voting rights following the cancellation will be 430,333,112 ordinary shares.
Glanbia plc (GLB) · 2026-06-12
Glanbia confirmed that Tirlán Co-operative Society Limited sold 12 million shares, representing a 5% stake, for €257.6 million. The transaction included an institutional placement and a €50 million directed buyback by Glanbia at €21.47 per share.
Golden Prospect Precious Metals Limited (GPM) · 2026-06-12
Golden Prospect Precious Metals Limited has called an Extraordinary General Meeting for 8 July 2026 to renew its share buyback authority. The company has already utilised the majority of the 15.2m share authority granted earlier in June.
TruFin intends to return £80m to shareholders following the disposal of Playstack Limited. The return comprises a £56.8m tender offer at 140p per share and a minimum £23.2m special dividend.
Allergy Therapeutics plc (AGY) · 2026-06-12
Allergy Therapeutics is presenting 15 research abstracts at the EAACI Congress 2026. Data confirms the Phase I/IIa PROTECT trial for VLP Peanut met its primary endpoint and achieved clinical proof of concept. Blinded Phase III paediatric safety data for Grass MATA MPL showed low discontinuation rates.
M.P. Evans Group PLC (MPE) · 2026-06-12
M.P. Evans reported a 10% increase in total crop harvested from Group-managed areas to 575,100 tonnes for the five months to May 2026. The producer said crude palm oil production rose 8% to 157,600 tonnes as oil-extraction rates improved to 24.2%.
Helios set the scrip dividend reference price at 214.1p per share. This applies to the 7.0p total dividend and 3.0p special dividend for the 2025 financial year. Shareholders must elect to participate by 26 June 2026.
GSK's momelotinib received Orphan Drug Designation from the FDA and EMA for VEXAS syndrome. The life-threatening condition currently has no approved treatments. A Phase II/III clinical trial is underway to support global regulatory submissions.
Henry Boot (BOOT) · 2026-06-12
Henry Boot PLC confirmed Edward Hutchinson will succeed Tim Roberts as Chief Executive Officer on 13 July 2026. Mr Roberts will step down from the Board on the same date, following the initial announcement on 8 May 2026.
energy B plc (NRGB) · 2026-06-12
energy B plc completed a £1.2m placing and signed a conditional £1m deal to acquire Horse Hill interests. It also named David Lenigas as Executive Chairman and withdrew its Bitcoin treasury strategy.
HUTCHMED (China) Limited (HCM) · 2026-06-12
HUTCHMED reported Phase III data for sovleplenib in warm antibody autoimmune hemolytic anemia (wAIHA). The study met its primary endpoint with a 66% durable response rate versus 15% for placebo. A New Drug Application is currently under priority review by regulators in China.
Glanbia plc (GLB) · 2026-06-12
Glanbia plc announced that Tirlán Co-Operative Society Limited sold 12m shares at €21.47 per share, raising €257.6m. The sale included a 9.7m share secondary placing and a 2.3m share directed buyback by Glanbia.
Kier Group plc (KIE) · 2026-06-12
Kier Group secured a c. £140m contract extension with South West Water. The two-year agreement for network services runs until March 2028 and appoints the group as sole contractor.
Severfield plc (SFR) · 2026-06-12
Severfield plc signed a new three-year banking facility agreement, replacing existing debt. The facilities include a £60m revolving credit facility and a £7.6m term loan featuring improved commercial terms and a reduced margin.
Pennant International Group plc (PEN) · 2026-06-12
Pennant International Group plc secured an IPS services framework with the Canadian Department for National Defence for up to C$35m over 11 years. The award supports maritime programmes using the company's Auxilium software suite.
African Pioneer Plc (AFP) · 2026-06-12
African Pioneer signed a non-binding term sheet with Xinhai for 100% funded development of its Namibian copper projects. Xinhai will subscribe for a 10% group stake and provide a project facility potentially convertible into a 74% interest in the project entity.
Caledonia Mining Corporation Plc (CMCL) · 2026-06-12
Executive Director Victor Gapare purchased 11,750 common shares at $18.70 per share through a discretionary trust. Following the purchase, Mr Gapare holds an interest in 2,455,122 shares, which represents approximately 12.70% of the issued share capital.
GCM Resources plc (GCM) · 2026-06-12
Using shares to pay for routine consulting and board fees preserves cash but indicates a reliance on equity as a primary currency.
Quadrise Plc (QED) · 2026-06-12
Quadrise Plc reports delays to its Utah project with Valkor Technologies LLC. Equipment delivery is pushed to Q3 2026 and $0.95m of a $1.0m licence fee remains outstanding pending Valkor's funding. The Board now expects payment in full by 30 September 2026.
MedPal AI plc (MPAL) · 2026-06-12
MedPal AI notes the UK Medicines and Healthcare products Regulatory Agency (MHRA) approval of the first oral GLP-1 for weight loss. The Board considers the approval "sooner than the market had anticipated," coinciding with the national launch of the company's New Health clinic.
Ariana Resources plc (AAU) · 2026-06-12
Non-Executive Director Chris Sangster transferred 3.9m shares between personal pension accounts for nil consideration. His total interest remains unchanged at 0.34% of the company's issued share capital.
Raspberry Pi Holdings plc (RPI) · 2026-06-12
CEO Eben Upton and Chief Commercial Officer (CCO) Mike Buffham sold a combined 250,000 shares in the company on 9 June 2026.
THG PLC reported its €445m Term Loan B is trading above par at its highest price since November 2021. The loan price has increased 500bps since January 2026, outperforming the European Leveraged Loan Index by c.400bps.
UK Oil & Gas PLC (UKOG) · 2026-06-12
UK Oil & Gas PLC agreed to sell its 85.635% interest in the Horse Hill field and PEDL137 licence for £1m cash. The company will use the proceeds to fund its UK salt cavern energy storage projects.
Pri0r1ty Intelligence Group PLC (PR1) · 2026-06-12
Pri0r1ty Intelligence Group reported revenue of £174,174 for FY25 and resumed trading on AIM today. The statutory loss of £10.3m was largely driven by a £7.0m one-off reverse takeover charge. Contracted revenue for the current year already exceeds £0.4m.
STV Group plc (STVG) · 2026-06-12
STV Group plc appointed Mark Hoad and Raj Mody as Independent Non-Executive Directors, effective 12 June 2026. Hoad will chair the Audit & Risk Committee.
Debenhams Group (DEBS) · 2026-06-12
Debenhams Group subleased its surplus 1.1 million square foot US distribution centre to ID Logistics, mitigating approximately $100m in future lease costs. The transaction generates a £40m non-cash credit in the H1 results. Group lease costs are expected to fall to £6m by 2029.
Henry Boot (BOOT) · 2026-06-12
Henry Boot appointed Warren Thompson as Managing Director for its Stonebridge Homes division. Thompson joins towards the end of 2026 from Keepmoat Homes and will become a member of the group's Executive and Investment Committees.
Flutter Entertainment plc (FLTR) · 2026-06-12
Flutter Entertainment intends to delist from the London Stock Exchange on 3 August 2026. The company concluded the move is in its best interests following a review of listing structures. Shares will continue to trade on the New York Stock Exchange.